Skip to main content
. Author manuscript; available in PMC: 2016 Jan 7.
Published in final edited form as: Neuron. 2015 Jan 7;85(1):11–26. doi: 10.1016/j.neuron.2014.10.047

Figure 4. Treatment-Specific Biomarker Candidates for Treatment of Depression.

Figure 4

Mean regional activity values for remitters and nonresponders segregated by treatment (either Escitalopram given as escitalopram oxalate or cognitive behavioral therapy (CBT)) are plotted for the 6 regions showing a significant treatment × outcome analysis of variance interaction effect. Regional metabolic activity values are displayed as region/whole-brain metabolism converted to z scores. From McGrath et al., 2013b.